Last reviewed: July 16, 2026 Last updated: July 16, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Our expert team is here to guide you towards achieving smooth, healthy skin from within.
The real advantage comes from working on the right things
But the stronger the meds, the more chance for changes to the libido, Lofton warns
Furthermore, the KDIGO 2024 guidelines cover combination therapy from the perspective of SGLT2is being first-line therapy, and long-acting GLP-1 RAs being an add-on in adults with CKD and T2D who have not achieved individualised glycaemic targets despite use of metformin and SGLT2is, or who are unable to use those medications [2]